NXTC (STOCKS)
NextCure, Inc. Common Stock
$8.121000
-0.049000 (-0.60%)
Prev close: $8.170000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael S. Richman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $72.33M
- Employees
- 43
- P/E (TTM)
- -0.78
- P/B (TTM)
- 2.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $43.90M |
| Research and Development | $27.20M |
| Other Operating Expenses | $16.71M |
| Operating Income/Loss | -$43.90M |
| Income/Loss From Continuing Operations After Tax | -$42.75M |
| Income/Loss From Continuing Operations Before Tax | -$42.75M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$42.75M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$42.75M |
| Net Income/Loss Available To Common Stockholders, Basic | -$42.75M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$8.71 |
| Diluted Earnings Per Share | -$8.71 |
| Basic Average Shares | 8,330,373 |
| Diluted Average Shares | 8,330,373 |
| Assets | $22.62M |
| Current Assets | $22.26M |
| Noncurrent Assets | $365.00K |
| Fixed Assets | $283.00K |
| Other Non-current Assets | $82.00K |
| Liabilities | $10.47M |
| Current Liabilities | $6.41M |
| Accounts Payable | $2.58M |
| Other Current Liabilities | $3.84M |
| Noncurrent Liabilities | $4.06M |
| Equity | $12.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $12.15M |
| Liabilities And Equity | $22.62M |
| Net Cash Flow From Operating Activities | -$36.98M |
| Net Cash Flow From Operating Activities, Continuing | -$36.98M |
| Net Cash Flow From Investing Activities | $25.79M |
| Net Cash Flow From Investing Activities, Continuing | $25.79M |
| Net Cash Flow From Financing Activities | $21.56M |
| Net Cash Flow From Financing Activities, Continuing | $21.56M |
| Net Cash Flow | $10.37M |
| Net Cash Flow, Continuing | $10.37M |
| Comprehensive Income/Loss | -$42.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$42.74M |
| Other Comprehensive Income/Loss | -$8.62M |